Daniel Gomez is the Chair of Radiation Oncology at NYU Langone’s Perlmutter Cancer Center and a pioneer in treating oligometastatic transition. Renowned for leading major clinical trials like NRG-LU002, he specializes in using advanced radiation technologies and molecular biomarkers to target tumors at their earliest ‘pre-progression‘ stages. His work focuses on integrating radiation with systemic therapies through multidisciplinary collaboration to improve outcomes for patients with complex cancers.
Welcoming him to the team, Perlmutter Cancer Center Director Anirban Maitra recently shared his excitement for the future of the program under Dr. Gomez’s leadership:
“Learn about Daniel Gomez, our Chair of Radiation Oncology at NYU Grossman School of Medicine, NYU Langone Health.
So excited to have Daniel here!
‘The cancer center is experiencing exponential growth, and there’s real institutional support for building new programs and advancing research.'”
Other articles featuring Anirban Maitra and Daniel Gomez on OncoDaily.